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Children bear a large burden of typhoid fever caused by Salmonella enterica serotype Typhi
(S. Typhi) in endemic areas. However, immune responses and clinical findings in children
are not well defined. Here, we describe clinical and immunological characteristics of young
children with S. Typhi bacteremia, and antimicrobial susceptibility patterns of isolated strains.
Methods
As a marker of recent infection, we have previously characterized antibody-in-lymphocyte
secretion (TPTest) during acute typhoid fever in adults. We similarly assessed membrane
preparation (MP) IgA responses in young children at clinical presentation, and then 7-10
days and 21-28 days later. We also assessed plasma IgA, IgG and IgM responses and T
cell proliferation responses to MP at these time points. We compared responses in young
children (1-5 years) with those seen in older children (6-17 years), adults (18-59 years), and
age-matched healthy controls.
Principal Findings
We found that, compared to age-matched controls patients in all age cohorts had signifi-
cantly more MP-IgA responses in lymphocyte secretion at clinical presentation, and the val-
ues fell in all groups by late convalescence. Similarly, plasma IgA responses in patients
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were elevated at presentation compared to controls, with acute and convalescent IgA and
IgG responses being highest in adults. T cell proliferative responses increased in all age co-
horts by late convalescence. Clinical characteristics were similar in all age cohorts, although
younger children were more likely to present with loss of appetite, less likely to complain of
headache compared to older cohorts, and adults were more likely to have ingested antibiot-
ics. Multi-drug resistant strains were present in approximately 15% of each age cohort, and
97% strains had resistance to nalidixic acid.
Conclusions
This study demonstrates that S. Typhi bacteremia is associated with comparable clinical
courses, immunologic responses in various age cohorts, including in young children, and
that TPTest can be used as marker of recent typhoid fever, even in young children.
Author Summary
The highest disease burden of typhoid fever caused by Salmonella enterica serotype Typhi
(S. Typhi) is seen in children under five years of age in endemic areas. We investigated
both mucosal and systemic immune responses in S. Typhi bacteremic young children
(aged, 1 to 5 years) by measuring S. Typhi membrane preparation (MP) specific IgA re-
sponse in lymphocyte culture secretion and plasma IgA, IgG and IgM responses using
ELISA. We also measured T cell proliferation responses using 3H-thymidine incorpo-
ration assay. We compared the responses to S. Typhi bacteremic older children (6 to 17
years) and adults (18 to 59 years) and with age-matched healthy controls (HC). Younger
children, older children and adults show comparable responses in lymphocyte secretions
after onset of illness. Plasma antibody responses to MP vary between young children and
other age groups. T cell proliferative responses increased in all age cohorts by late conva-
lescence. Clinical characteristics were similar in all age cohorts. Emergence of MDR S.
Typhi strains is seen in young children which does not impact on the clinical symptoms or
the immune responses. The results of this study show that natural infections do induce im-
mune response in young children as well as in adults.
Introduction
Human restricted Salmonella enterica serotype Typhi (S. Typhi) causes typhoid fever and glob-
ally, more than 21 million cases of S. Typhi infection and 216,510 deaths due to typhoid fever
are reported each year [1]. In endemic areas such as Bangladesh and India, young children
under 5 years of age bear a large burden of S. Typhi infection [2–6], although it has been sug-
gested that typhoid fever may be less severe in such young children [7,8]. In reality, the immu-
nological responses and clinical characteristics in young children with S. Typhi bacteremia
have to date remained poorly characterized. Similarly, it has also been suggested that infection
with multi-drug resistant (MDR: resistant to ampicillin, chloramphenicol, trimethoprim/
sulfamethoxazole) S. Typhi may impact clinical severity and outcome [9], although little is
known about MDR S. Typhi infection in young children.
To address these issues, we assessed the clinical characteristics of S. Typhi bacteremic young
children in Dhaka, Bangladesh and determined the antibiotic susceptibility profiles of isolated
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strains. We compared clinical characteristics between children infected with MDR S. Typhi
and with non MDR S. Typhi. We also assessed humoral and cellular immune responses in
S. Typhi bacteremic young children, and compared these responses to those in infected older
children and adults, as well as to age-matched healthy controls. We assessed humoral responses
in plasma, as well as antibodies recovered from circulating lymphocytes secretion using a previ-
ously described assay as a marker of recent infection [10,11]. We also characterized the cell me-
diated immune responses to S. Typhi MP antigen in the bacteremic children.
Materials and Methods
Enrollment of participants and blood collection
In this study, we enrolled suspected typhoid fever patients from field sites and the Dhaka hospi-
tal of the icddr,b based on the criteria of fever of at least 38°C with a minimum duration of 3
days. Blood was collected from patients at the day of enrolment (T1), then at early convales-
cence 7–10 days later (T2) and at late convalescence 21–28 days (T3) after the S. Typhi bacter-
emia. We categorized our patients into three groups based on their age: Group I (young
children; 1–5 years of age; N = 33), Group II (older children; 6–17 years of age; N = 23), and
Group III (adults; 18–59 years of age; N = 16). We also collected a single blood sample from
healthy controls (N = 20 in each age group) who also resided in the same typhoid endemic area.
Ethics statement
We obtained informed written consent from all study participants or their guardians prior to
study enrollment. This study was approved by the Research Review Committee (RRC) and the
Ethical Review Committee (ERC) of the icddr,b and Institutional Review Board of the Massa-
chusetts General Hospital.
Blood culture and susceptibilities
Blood was cultured using a BacT/Alert automated system, and positive cultures were character-
ized using standard bacteriological procedures as previously described [11]. Antimicrobial sus-
ceptibility profiles were assessed by the disc diffusion method and resistance was determined
per Clinical and Laboratory Standards Institute (CLSI) guideline as needed [12]. The suscepti-
bility to azithromycin was determined following the zone size used for Enterobacteriaceae [13].
Preparation of antibodies recovered from circulating lymphocytes
We recovered antibodies secreted by peripheral lymphocytes (the TPTest; antibody in lympho-
cyte secretion) as previously described [10,14]. Briefly, we diluted whole blood with equal vol-
ume of phosphate-buffered saline (PBS), and added the sample on Ficoll-Isopaque (Pharmacia,
Upsala, Sweden), centrifuging at 772×g for 25 min. Plasma was separated from the top and
stored at -20°C for use for plasma antibody analyses. We then collected and washed the
PBMCs, resuspended the cells in RPMI (Gibco, Gaithersburg, MD) complete medium at a con-
centration of 1×107 cells per ml of medium, and incubated the samples at 37°C in a 5% CO2 in-
cubator for 48 hours. We then collected the secretion and stored the samples at -70°C until
antibody analyses was carried out by enzyme linked immunosorbent assay (ELISA) [10].
Antigen preparation and measurement of antibodies in plasma and
using the TPTest
S. Typhi specific membrane preparation (MP) antigen was used for the measurement of anti-
bodies (IgA antibody-in-lymphocyte secretion, and IgA, IgG and IgM antibodies in plasma) by
Immune Responses in Young Children with Typhoid Fever
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ELISA. The MP antigen was prepared from strain S. Typhi Ty21a as described previously [15].
In brief, we cultured strain Ty21a on horse blood agar plates and harvested with Tris buffer (10
mM Tris [pH 8.0], 5 mMMgCl2). We then sonicated the mixture, followed by differential cen-
trifugation, and determined the protein content using the Bio-Rad protein assay [16]. We coat-
ed microtiter plates (Nunc F, Denmark) with MP antigen (2 μg/ml for plasma, 10 μg/ml
for lymphocyte secretion) [14] at room temperature overnight. Following blocking with 1% bo-
vine serum albumin in PBS, we added 100 μl of lymphocyte secretion (1:2 in 0.1% BSA in
PBS-Tween for IgA) or plasma (1:25 dilution for IgA and IgM, and 1:50 dilution for IgG), and
incubated the plates for 90 min at 37°C. We then washed the plates with 0.05% PBS-Tween,
and added horseradish peroxidase-conjugated antibodies to either human IgA, IgG (Jackson
Laboratories, Bar Harbor, ME) or IgM (Southern Biotech, Birmingham, AL) (1:1000 in 0.1%
BSA in PBS-Tween for IgA, IgG and IgM). We developed the plates with ortho-phenylene di-
amine (Sigma Chemical Co., St. Louis, MO) in 0.1M sodium citrate buffer and 0.1% hydrogen
peroxide. We read the plates kinetically at 450 nm for five minutes at 19-second intervals, and
expressed the maximal rate of optical density (OD) change as milli-optical density absorbance
units per minute (mAB/min) [14]. We used pooled convalescent plasma from previous patients
with known typhoid fever as a positive control on each plate to correct for variations between
plates and different days of testing, and divided kinetic reading by this pool, expressing results
as ELISA units as previously described [10,14].
T-cell proliferation assay
For T cell proliferation assays, we re-suspended isolated PBMCs in DMEM complete medium
[DMEM/F12 medium (Gibco, GlutaMAX) supplemented with 1% gentamicin and 5% human
AB serum] at a concentration of 1x106 cells/ml of medium. We used MP antigen (5 μg/ml) for
the stimulation of the cells in tissue culture plates. We used phytohaemagglutinin (PHA)
[Murex Diagnostics Ltd, Temple Hill, UK] as a positive control, and keyhole limpet hemocya-
nin (KLH) as a negative control. We incubated plates at 37°C with 5% CO2 for 5 days. From
the top of each well, 100 μl of the medium was replaced with fresh medium without disturbing
the cells at the bottom after 48 hours of incubation. We added 3H-thymidine (1 μCi) to each
well on the 5th day of incubation, and incubated the plates for an additional eight hours after
which cells were harvested (Skatron instruments, Norway) in Bray’s scintillation fluid (Ultima-
gold, PerkinElmer, Boston, MA), and 3H-thymidine incorporation was assessed using a liquid
scintillation β-counter (Beckman LS6500 multipurpose scintillation counter, USA) [17–19].
We expressed results as counts per minute (cpm), and calculated stimulation indices to deter-
mine the responses using specimens collected at T2 and T3 [17,20].
Statistical analyses
Analysis of data and preparation of figures used statistical software SigmaStat (version3.1),
Prism4 and Epi Info7 (Centers for Disease Control and Prevention). Statistical evaluation of
differences between study days was performed using the Wilcoxon Signed Rank test, and
among groups was performed using the unpaired t test. Results were considered statistically
significant if p<0.05.
Results
Clinical characteristics of patients with typhoid fever
Among 33 S. Typhi bacteremic young children, 8 (24%) patients reported prior antibiotic use,
and the median temperature and mean duration of fever were 39.1°C and 4.6 days, respectively
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(Table 1). Out of the total 72 S. Typhi bacteremic patients, significantly higher number of adults
had a history of antibiotic taken before enrolment than older children (n = 6, 38% vs. n = 2, 9%;
p = 0.028). No significant differences were found in median temperature or duration of fever be-
tween young children and older age groups. Although there was a significant difference in the me-
dian pulse rate among groups, the values reflected age variation in pulse rate irrespective of illness.
Young patients presented with a number of the classical features of typhoid fever, including
high grade fever (median temperature: 39.1°C), abdominal pain (n = 7, 21%), loss of appetite
(n = 19, 58%) and coated tongue (n = 6, 18%). The number of patients reporting myalgia was
significantly higher in adults than younger children (n = 13, 81% vs. n = 6, 15%; p = 0.00002)
and older children (n = 13, 81% vs. n = 4, 17%; p = 0.00007). A significantly lower proportion
of young patients communicated complaints of headache compared to older children (n = 4,
12% vs. n = 8, 35%; p = 0.04) and adults (n = 4, 12% vs. n = 10, 63%; p = 0.0002); whereas the
number of patients with loss of appetite was higher in young children compared to older chil-
dren (n = 19, 58% vs. n = 7, 30%; p = 0.04). All study participants were treated with antimicro-
bials and hospitalized at the discretion of the attending physician. All patients recovered, and
none developed severe complications such as intestinal hemorrhage or perforation, or enceph-
alopathy as they were appropriately treated.
Antibiotic susceptibility profiles of strains isolated from patients with
S. Typhi bacteremia
In young children, the number of isolates with resistance to ampicillin, chloramphenicol
and co-trimoxazole was 13 (39%), 10 (30%) and 10 (30%), respectively; and 5 (15%) isolated
Table 1. Baseline information and clinical characteristics of patients with typhoid fever.
Parameters Young children Older children Adults
Baseline Information
Number of S. Typhi bacteremic patients 33 23 16
No. of males (%) 19 (58) 10 (43) 4 (25)
Median age in year (25th, 75th centile) 3.2 (2.4, 4.1) 8.4 (6.3, 11.6) 28.4 (24.4, 34.5)
Median temperature in °C (25th, 75th centile) 39.1 (39.0, 39.4) 39.0 (38.5, 39.3) 39.0 (38.5, 39.2)
Duration of fever, days (mean ± standard deviation) 4.6 ± 1.2 4.1 ± 1.2 5.0 ± 0.8
Median pulse/min (25th, 75th centile) 130 (120, 140) 110 (100, 119.5)a 90 (88, 92)ab
No. of patients receiving antibiotic before enrolment (%) 8 (24) 2 (9) 6 (38)b
Clinical features
No. of patients (%) with:
Diarrhea 10 (30) 9 (39) 6 (38)
Abdominal pain 7 (21) 5 (22) 3 (19)
Loss of appetite 19 (58) 7 (30)a 6 (38)
Headache 4 (12) 8 (35)a 10 (63)a
Myalgia 6 (15) 4 (17) 13 (81)ab
Rash 0 (0) 0 (0) 0 (0)
Coated tongue 6 (18) 6 (26) 6 (38)
Tender abdomen 2 (6) 0 (0) 0 (0)
Hepatomegaly 0 (0) 0 (0) 0 (0)
Splenomegaly 0 (0) 0 (0) 0 (0)
a p < 0.05 when compared to young children
b p < 0.05 when compared to older children
doi:10.1371/journal.pntd.0003619.t001
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strains were MDR. Of 23 S. Typhi strains isolated from older children, 6 (26%), 3 (13%) and
3 (13%) were resistant to ampicillin, chloramphenicol and co-trimoxazole, respectively; and 3
(13%) were MDR. Among 16 isolates from adults, 2 (13%) were MDR strains. All 72 (100%)
strains isolated from the three age groups were sensitive to cephalosporins (ceftriaxone and
cefixime) and to azithromycin, although 70 (97%) strains had reduced susceptibility to cipro-
floxacin and resistance to nalidixic acid, with all the isolates in young children having reduced
susceptibility to ciprofloxacin (Table 2). No isolate was sensitive for ciprofloxacin. We found
no significant differences in the number of patients requiring hospitalization nor in other clini-
cal characteristics between MDR and non MDR S. Typhi infections in either young children or
the older age groups. We also compared the clinical characteristics between nalidixic acid resis-
tant (NAR) and non-NAR isolates and did not find any difference.
S. Typhi specific MP-IgA responses in lymphocyte secretions
At enrollment (T1), young children had significantly higher MP-IgA responses in lymphocyte
secretions than at early (T2) and late (T3) convalescent stages (Fig. 1). The responses in young
healthy control children were significantly lower than in the patients at all three stages of the
infection (p<0.0001). A sub-analysis of responses when stratified by ingestion of antibiotics
prior to presentation showed similar results. S. Typhi bacteremic young children had similar
MP-IgA responses in lymphocyte secretions as did older children and adults at the early stage
of the disease (T1). The differences in response were seen mainly at later stages of the disease
(T2 and T3). At T2, there was a significantly higher response in older compared to younger
children (p = 0.0186). The responses in young children were also lower than those in adults at
T2 (p< 0.0001) and at T3 (p = 0.0086). The patients in all age groups had significantly higher
responses (p< 0.0001) in lymphocyte secretions than in those of their age-matched healthy
controls (Fig. 1).
Plasma antibody responses to S. Typhi specific MP in children and adult
patients with typhoid fever
In plasma, young children had significantly higher MP-IgA responses at all time points com-
pared to age-matched healthy controls, similar to both older cohorts. The plasma values were
highest in adults (Fig. 2a). In the plasma-MP-IgG analyses, adults showed higher responses
Table 2. Antibiotic susceptibility pattern of isolated strains from the patients of three age groups.
Antibiotics Young children (n = 33) Older children (n = 23) Adults (n = 16)
Resistance to ampicillin 13 (39) 6 (26) 2 (13)
Resistance to chloramphenicol 10 (30) 3 (13) 2 (13)
Resistance to co-trimoxazole 10 (30) 3 (13) 2 (13)
MDR* 5 (15) 3 (13) 2 (13)
Resistance to nalidixic Acid 33 (100) 23 (100) 14 (88)a
Reduced susceptibility to ciproﬂoxacin 33 (100) 23 (100) 14 (88)a
Resistance to ceftriaxone 0 (0) 0 (0) 0 (0)
Resistance to ceﬁxime 0 (0) 0 (0) 0 (0)
Resistance to azithromycin 0 (0) 0 (0) 0 (0)
Results are n (%).
*MDR, multidrug-resistant (resistant to ampicillin, chloramphenicol and co-trimoxazole).
a p < 0.05 when compared to young children.
doi:10.1371/journal.pntd.0003619.t002
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than healthy controls at all three time points, while there were no statistically different in-
creases in MP IgG responses compared to age-matched healthy controls in either younger or
older children, except for a slight increase in MP IgG at T3 in the younger children (Fig. 2b).
The plasma-MP-IgM analyses were similar to the plasma IgG results. Adults showed signifi-
cantly higher responses at all three time points compared to age-matched healthy controls,
while there were no significant increases in older children at any time point, and small in-
creases at T2 and T3 in younger children (Fig. 2c).
T cell proliferative response in patients with S. Typhi bacteremia
We compared T cell proliferative responses to S. Typhi MP antigen in young healthy controls
and in children with typhoid fever at early (T2) and late (T3) convalescence (Fig. 3). T cell pro-
liferative assays following S. Typhi MP stimulation increased in all age cohorts by late convales-
cence. We did not detect any difference in proliferative indices between healthy controls and
children at early convalescence, but infected children had significantly higher proliferative re-
sponses at late convalescence compared to healthy controls (p = 0.001) and compared to early
stage of convalescence (p = 0.038). We found no difference in T cell proliferative responses to
Fig 1. MP-IgA responses in lymphocyte culture secretion in patients with S. Typhi bacteremia.Mean with standard error of mean (SEM) are shown for
T1 (at day of enrolment), T2 (at early convalescence: 7–10 days after enrolment) and T3 (at late convalescence: 21–28 days after enrolment). Statistical
difference between patients and age-matched healthy control (HC): *. MP: S. Typhi membrane preparation.
doi:10.1371/journal.pntd.0003619.g001
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S. Typhi MP antigen in early (T2) and late convalescent stage (T3) of the disease between bac-
teremic young children and older age groups (Fig. 3).
Discussion
This study characterizes humoral and cellular immune responses during typhoid fever with con-
firmed S. Typhi bacteremia, the clinical picture of the disease, and the current antibiotic suscep-
tibility patterns of S. Typhi strains in young children in Dhaka, Bangladesh. This age group
would be a primary target for typhoid control and vaccination programs. Our main finding was
that young children had comparable clinical, microbiologic and immune features compared to
those seen in older children and adults. These observations support the use of typhoid control
and vaccination strategies in children under five years of age. In particular, our observation that
approximately 15% of S. Typhi isolates were multi drug resistant and that resistance to nalidixic
acid and decreased susceptibility to ciprofloxacin are now common in Dhaka, including in the
Fig 2. Plasma antibody responses to MP in patients with S. Typhi bacteremia. Anti-MP-IgA (2a), anti-MP-IgG (2b) and anti-MP-IgM (2c) responses are
shown as mean with standard error of mean (SEM) for T1 (at day of enrolment), T2 (at early convalescence: 7–10 days after enrolment) and T3 (at late
convalescence: 21–28 days after enrolment). Statistical difference between patients and age-matched healthy control (HC): *. MP: S. Typhi
membrane preparation.
doi:10.1371/journal.pntd.0003619.g002
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youngest children, suggest that options for antimicrobial therapy are becoming limited, and
should be viewed as a strong reason to support typhoid control and vaccination programs. Al-
though no complications due to typhoid fever were seen in our study patients, the clinical fea-
tures of S. Typhi infection in young children was similar to those seen in older children and
adults, the age cohorts traditionally thought to bear the largest burden of disease [7,8,21].
Similarly, we were unable to find an association between infection with MDR strains and
disease severity, although previous studies [22–24] report such an association. Our finding,
however, is in agreement with a study carried out in New Delhi [2].
Our study includes one of the first analyses of the range of immune responses following ty-
phoid fever in young children. We have previously shown that antibodies secreted by lympho-
cytes circulating in the peripheral blood of adults with typhoid and paratyphoid fever increase
transiently during typhoid fever, and that these responses can be used as both a sensitive and
specific diagnostic assay to identify patients with enteric fever [10,14]. These activated lympho-
cytes may represent cells activated early in infection either at the mucosal surface or in systemic
sites. Our results suggest that the lymphocytes of young children with S. Typhi bacteremia are
similarly activated as those of older children and adults. Our results also suggest that an assay
such as the previously described Typhoid Paratyphoid Test (TPTest), which is based on assess-
ing antibodies secreted by circulating lymphocytes, can be used to identify young children with
typhoid fever. The results in this current report suggest that this assay can distinguish infected
from non-infected children in this endemic zone, and that the transient nature of the response
(falling to baseline by late convalescence) would support its further development as a diagnos-
tic assay early in disease, to assist with disease burden analyses, and to help target and assess
Fig 3. T-cell proliferation responses in patients with S. Typhi bacteremia. T-cell proliferation responses against S. Typhi specific membrane preparation
(MP), control proteins phytohaemagglutinin (PHA) and keyhole limpet hemocyanin (KLH) at early and late convalescent stages of disease in S. Typhi
bacteremic patients and in healthy controls (HC). Stimulation index was calculated as the ratio of net cpm with antigen to net cpm without antigen (only
media). Mean with standard error of mean (SEM) are shown for T1 (at day of enrolment), T2 (at early convalescence: 7–10 days after enrolment) and T3 (at
late convalescence: 21–28 days after enrolment). Statistical difference between patients and age-matched healthy control (HC): *.
doi:10.1371/journal.pntd.0003619.g003
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control and vaccination programs. We found higher response in older children and adults to
MP stimulation in lymphocyte culture supernatant at later stages of the disease (T2 and T3
time points) which may be due to previous exposure and specific immunity developed to
S. Typhi. Our results also suggest that the plasma IgA response against S. Typhi membrane
preparation could also be used to identify acutely infected patients. However, the magnitude of
these responses was appreciably lower in young children compared to adults which may be
also due to previous exposure. Our results suggest that IgG and IgM responses against MP
would have limited clinical utility in endemic setting.
We have previously characterized the cellular immune responses in adult patients with ty-
phoid fever [17]. Our current analysis suggests that even young children develop proliferative
responses to typhoid antigens by late convalescence. Significant responses to S. Typhi MP even
in healthy adults also suggest that baseline proliferative responses may increase over time in
this typhoid endemic area. The reason for lower stimulation index among healthy control in
older children compared to young children and adults is not currently clear.
Our study has a number of limitations. We (1) only assessed immune responses against a
crude S. Typhi antigen preparation as in our earlier studies [10,11] and not purified antigens;
(2) we used a proliferative assay to characterize cellular immunity and did not further charac-
terize specific immune mechanistic pathways; (3) our study was only of moderate size; and (4)
our study was hospital-based and did not involve active community-based case detection. De-
spite these limitations, our study is the largest to date characterizing humoral and cellular im-
mune responses, clinical features and microbiologic susceptibility profiles in young children
with bacteremic typhoid fever. Our results suggest that young children with S. Typhi bacter-
emia develop a clinical illness and host immune responses comparable to those seen in older
children and adults. Our results also support the further development of the TPTest as a diag-
nostic assay for enteric fever, for use in estimating disease burden and the effects of control and
vaccination programs across the different age cohorts.
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